AMOYTOP

Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; clinical medical reagents; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations, namely, antivirals; human growth hormone; medicinal preparations for the mouth and as sprays; nasal spray preparations; nutritional supplements